Theratechnologies (THTX) News Today $1.67 -0.19 (-10.22%) Closing price 04:00 PM EasternExtended Trading$1.61 -0.06 (-3.59%) As of 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Theratechnologies rises after FDA label expansion for best seller EgriftaMarch 26 at 1:06 PM | msn.comTheratechnologies Receives FDA Approval for EGRIFTA WR (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyMarch 26 at 8:06 AM | finanznachrichten.deTheratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyMarch 25 at 6:02 PM | financialpost.comTheratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyMarch 25 at 5:45 PM | globenewswire.comTheratechnologies Reports Encouraging Results From PROMISE-US Trial Of IbalizumabMarch 14, 2025 | nasdaq.comTheratechnologies presents data on limitations of using BMI to assess CV riskMarch 12, 2025 | markets.businessinsider.comTheratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIVMarch 12, 2025 | financialpost.comTheratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIVMarch 12, 2025 | globenewswire.comTheratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROIMarch 12, 2025 | globenewswire.comJonesTrading Reaffirms Their Hold Rating on Theratechnologies (THTX)March 5, 2025 | markets.businessinsider.comWhat is Leede Financial's Forecast for THTX FY2027 Earnings?Theratechnologies Inc. (NASDAQ:THTX - Free Report) - Leede Financial issued their FY2027 EPS estimates for Theratechnologies in a report issued on Wednesday, February 26th. Leede Financial analyst D. Loe expects that the company will post earnings of $0.23 per share for the year. The consensus esMarch 1, 2025 | marketbeat.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest Up 212.7% in FebruaryTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the target of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 31,900 shares, a growth of 212.7% from the January 31st total of 10,200 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 123,000 shares, the short-interest ratio is currently 0.3 days.February 28, 2025 | marketbeat.comWhat is Leede Financial's Estimate for THTX FY2025 Earnings?Theratechnologies Inc. (NASDAQ:THTX - Free Report) - Research analysts at Leede Financial lowered their FY2025 earnings estimates for shares of Theratechnologies in a research report issued to clients and investors on Wednesday, February 26th. Leede Financial analyst D. Loe now expects that the cFebruary 27, 2025 | marketbeat.comTheratechnologies Inc. (THTX) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comTheratechnologies (NASDAQ:THTX) Posts Earnings ResultsTheratechnologies (NASDAQ:THTX - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.14).February 26, 2025 | marketbeat.comTheratechnologies (NASDAQ:THTX) Announces Quarterly Earnings Results, Misses Expectations By $0.14 EPSTheratechnologies (NASDAQ:THTX - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.14).February 26, 2025 | marketbeat.comTheratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024February 26, 2025 | globenewswire.comTheratechnologies upgraded to Buy from Speculative Buy at Mackie ResearchFebruary 14, 2025 | markets.businessinsider.comTheratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business UpdateFebruary 14, 2025 | globenewswire.comTheratechnologies to resume distribution of EGRIFTAFebruary 14, 2025 | markets.businessinsider.comTheratechnologies Resumes Distribution of EGRIFTA SV®February 13, 2025 | financialpost.comTheratechnologies Resumes Distribution of EGRIFTA SV®February 13, 2025 | financialpost.comTheratechnologies Resumes Distribution of EGRIFTA SV®February 13, 2025 | globenewswire.comShort Interest in Theratechnologies Inc. (NASDAQ:THTX) Drops By 73.4%Theratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 10,200 shares, a decline of 73.4% from the January 15th total of 38,400 shares. Based on an average daily volume of 103,600 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.1% of the company's stock are sold short.February 12, 2025 | marketbeat.comTheratechnologies (THTX) to Release Quarterly Earnings on WednesdayTheratechnologies (NASDAQ:THTX) will be releasing earnings before the market opens on Wednesday, February 19, Financial Modeling Prep reports.February 12, 2025 | marketbeat.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest Down 53.5% in JanuaryTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totalling 38,400 shares, a decrease of 53.5% from the December 31st total of 82,500 shares. Approximately 0.2% of the company's stock are short sold. Based on an average daily volume of 93,600 shares, the short-interest ratio is currently 0.4 days.January 30, 2025 | marketbeat.comTheratechnologies (NASDAQ:THTX) Trading Down 0.6% - Time to Sell?Theratechnologies (NASDAQ:THTX) Shares Down 0.6% - Time to Sell?January 18, 2025 | marketbeat.comTheratechnologies (NASDAQ:THTX) Shares Down 0.6% - Time to Sell?Theratechnologies (NASDAQ:THTX) Trading Down 0.6% - What's Next?January 18, 2025 | marketbeat.comTheratechnologies issues update on Egrifta SV shortageJanuary 9, 2025 | msn.comTheratechnologies Provides Update on EGRIFTA SV® SupplyJanuary 9, 2025 | financialpost.comTheratechnologies Provides Update on EGRIFTA SV® SupplyJanuary 9, 2025 | globenewswire.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest UpdateTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 72,200 shares, a growth of 64.8% from the November 30th total of 43,800 shares. Based on an average daily volume of 72,500 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.4% of the shares of the stock are sold short.December 27, 2024 | marketbeat.comTheratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing EnvironmentDecember 18, 2024 | globenewswire.comTheratechnologies Inc. (NASDAQ:THTX) Sees Large Decline in Short InterestTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 43,800 shares, a decline of 44.0% from the November 15th total of 78,200 shares. Based on an average trading volume of 48,900 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.2% of the shares of the stock are sold short.December 12, 2024 | marketbeat.comTheratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLADecember 10, 2024 | financialpost.comTheratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLADecember 10, 2024 | globenewswire.comTheratechnologies announces preliminary tolerability, efficiacy data for TH1902December 9, 2024 | markets.businessinsider.comTheratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian CancerDecember 9, 2024 | globenewswire.comTheratechnologies enters exclusive licensing agreement with IonisDecember 4, 2024 | markets.businessinsider.comIonis Grants Theratechnologies License To Commercialize Olezarsen And Donidalorsen For Use In CanadaDecember 4, 2024 | markets.businessinsider.comTheratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in CanadaDecember 4, 2024 | globenewswire.comTheratechnologies resumes production of Egrifta SVDecember 3, 2024 | markets.businessinsider.comTheratechnologies Announces Resumed Production of EGRIFTA SV®December 3, 2024 | globenewswire.comTheratechnologies secures up to $75M in new credit facilitiesDecember 2, 2024 | markets.businessinsider.comTheratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement QuébecDecember 2, 2024 | financialpost.comTheratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement QuébecDecember 2, 2024 | globenewswire.comTheratechnologies Inc. THTX (U.S.: Nasdaq)November 28, 2024 | wsj.comTheratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA ReviewNovember 26, 2024 | globenewswire.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest Up 26.8% in OctoberTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 43,000 shares, a growth of 26.8% from the October 15th total of 33,900 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 33,400 shares, the short-interest ratio is currently 1.3 days.November 15, 2024 | marketbeat.comTheratechnologies Inc. (THTX) Stock Price, News, Quote & History - Yahoo FinanceOctober 26, 2024 | finance.yahoo.com Remove Ads Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address THTX Media Mentions By Week THTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THTX News Sentiment▼0.920.78▲Average Medical News Sentiment THTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THTX Articles This Week▼61▲THTX Articles Average Week Remove Ads Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CMPS News Today SEPN News Today CADL News Today DSGN News Today AVIR News Today CRVS News Today MBX News Today IMMP News Today PRME News Today SLRN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:THTX) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
